160 related articles for article (PubMed ID: 25550826)
1. Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer.
Liu B; Xu K; Jiang Y; Li X
Int J Clin Exp Pathol; 2014; 7(11):7863-71. PubMed ID: 25550826
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].
Chi C; He ZF; Liu Y; Lin XM; Sun CC
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):129-31. PubMed ID: 23714668
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer.
Zhao H; Zeng ZL; Yang J; Jin Y; Qiu MZ; Hu XY; Han J; Liu KY; Liao JW; Xu RH; Zou QF
Int J Clin Exp Pathol; 2014; 7(2):619-30. PubMed ID: 24551282
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
6. Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Wang ZM
Int J Clin Exp Pathol; 2015; 8(1):601-7. PubMed ID: 25755751
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
8. OTUD7B and NIK expression in non-small cell lung cancer: Association with clinicopathological features and prognostic implications.
Zhang B; Wang H; Yang L; Zhang Y; Wang P; Huang G; Zheng J; Ren H; Qin S
Pathol Res Pract; 2016 Oct; 212(10):893-898. PubMed ID: 27499151
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
[TBL] [Abstract][Full Text] [Related]
11. High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival.
Zhang S; Zhai X; Wang G; Feng J; Zhu H; Xu L; Mao G; Huang J
Int J Clin Exp Pathol; 2015; 8(1):541-50. PubMed ID: 25755744
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
[TBL] [Abstract][Full Text] [Related]
14. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
15. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
16. Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis.
Zhang J; Lv H; Ji M; Wang Z; Wu W
PLoS One; 2020; 15(5):e0233508. PubMed ID: 32437452
[TBL] [Abstract][Full Text] [Related]
17. Regulator of G-protein signaling 4: A novel tumor suppressor with prognostic significance in non-small cell lung cancer.
Cheng C; Yue W; Li L; Li S; Gao C; Si L; Tian H
Biochem Biophys Res Commun; 2016 Jan; 469(3):384-91. PubMed ID: 26640232
[TBL] [Abstract][Full Text] [Related]
18. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].
Qi RX; Xu XY
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798
[TBL] [Abstract][Full Text] [Related]
19. Circadian clock gene Per2 downregulation in non‑small cell lung cancer is associated with tumour progression and metastasis.
Xiang R; Cui Y; Wang Y; Xie T; Yang X; Wang Z; Li J; Li Q
Oncol Rep; 2018 Nov; 40(5):3040-3048. PubMed ID: 30226549
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis.
Li YY; Jin F; Zhou JJ; Yu F; Duan XF; He XY; Wang R; Wu WL; Long JH; Luo XL
Chronobiol Int; 2019 Dec; 36(12):1723-1732. PubMed ID: 31609143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
